Submission Details
| 510(k) Number | K092767 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 09, 2009 |
| Decision Date | August 20, 2010 |
| Days to Decision | 345 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K092767 is an FDA 510(k) clearance for the BBL CHROMAGAR MRSA II, a Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar (Class II — Special Controls, product code JSO), submitted by Becton, Dickinson & CO (Sparks, US). The FDA issued a Cleared decision on August 20, 2010, 345 days after receiving the submission on September 9, 2009. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1700.
| 510(k) Number | K092767 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 09, 2009 |
| Decision Date | August 20, 2010 |
| Days to Decision | 345 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | JSO — Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.1700 |